Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report

Amy D. Klion, Bruce S. Bochner, Gerald J. Gleich, Thomas B. Nutman, Marc E. Rothenberg, Hans Uwe Simon, Michael E. Wechsler, Peter F. Weller, Hypereosinophilic Syndromes Working Group the Hypereosinophilic Syndromes Working Group

Research output: Contribution to journalArticle

Abstract

Hypereosinophilic syndromes are a heterogeneous group of uncommon disorders characterized by the presence of marked peripheral blood eosinophilia, tissue eosinophilia, or both, resulting in a wide variety of clinical manifestations. Although corticosteroids are the first-line therapy for many of these disorders, approaches to the treatment of patients who do not tolerate or are unresponsive to corticosteroids are poorly standardized. A multidisciplinary group of 37 clinicians and scientists participated in a workshop held in May 2005 in Bern, Switzerland to discuss current and future approaches to therapy for 3 eosinophil-mediated disorders: hypereosinophilic syndrome, Churg-Strauss syndrome, and eosinophil-associated gastrointestinal disease. The goal of the workshop was to summarize available data regarding treatment of these disorders to identify the most promising therapies and approaches for further study. There was consensus among all of the participants that the identification of markers of disease progression to assess treatment responses is a research priority for all 3 disorders. Furthermore, the need for newer therapeutic strategies and novel drugs, as well as multicenter trials to assess all treatment modalities, was emphasized.

Original languageEnglish (US)
Pages (from-to)1292-1302
Number of pages11
JournalThe Journal of Allergy and Clinical Immunology
Volume117
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Hypereosinophilic Syndrome
Education
Eosinophilia
Therapeutics
Eosinophils
Adrenal Cortex Hormones
Churg-Strauss Syndrome
Gastrointestinal Diseases
Switzerland
Multicenter Studies
Disease Progression

Keywords

  • Churg-Strauss syndrome
  • Eosinophil
  • eosinophil-associated gastrointestinal disease
  • hypereosinophilic syndromes
  • treatment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Klion, A. D., Bochner, B. S., Gleich, G. J., Nutman, T. B., Rothenberg, M. E., Simon, H. U., ... the Hypereosinophilic Syndromes Working Group, H. S. W. G. (2006). Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report. The Journal of Allergy and Clinical Immunology, 117(6), 1292-1302. https://doi.org/10.1016/j.jaci.2006.02.042

Approaches to the treatment of hypereosinophilic syndromes : A workshop summary report. / Klion, Amy D.; Bochner, Bruce S.; Gleich, Gerald J.; Nutman, Thomas B.; Rothenberg, Marc E.; Simon, Hans Uwe; Wechsler, Michael E.; Weller, Peter F.; the Hypereosinophilic Syndromes Working Group, Hypereosinophilic Syndromes Working Group.

In: The Journal of Allergy and Clinical Immunology, Vol. 117, No. 6, 06.2006, p. 1292-1302.

Research output: Contribution to journalArticle

Klion, AD, Bochner, BS, Gleich, GJ, Nutman, TB, Rothenberg, ME, Simon, HU, Wechsler, ME, Weller, PF & the Hypereosinophilic Syndromes Working Group, HSWG 2006, 'Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report', The Journal of Allergy and Clinical Immunology, vol. 117, no. 6, pp. 1292-1302. https://doi.org/10.1016/j.jaci.2006.02.042
Klion, Amy D. ; Bochner, Bruce S. ; Gleich, Gerald J. ; Nutman, Thomas B. ; Rothenberg, Marc E. ; Simon, Hans Uwe ; Wechsler, Michael E. ; Weller, Peter F. ; the Hypereosinophilic Syndromes Working Group, Hypereosinophilic Syndromes Working Group. / Approaches to the treatment of hypereosinophilic syndromes : A workshop summary report. In: The Journal of Allergy and Clinical Immunology. 2006 ; Vol. 117, No. 6. pp. 1292-1302.
@article{a23164cddc234c92a29306ccb9135b08,
title = "Approaches to the treatment of hypereosinophilic syndromes: A workshop summary report",
abstract = "Hypereosinophilic syndromes are a heterogeneous group of uncommon disorders characterized by the presence of marked peripheral blood eosinophilia, tissue eosinophilia, or both, resulting in a wide variety of clinical manifestations. Although corticosteroids are the first-line therapy for many of these disorders, approaches to the treatment of patients who do not tolerate or are unresponsive to corticosteroids are poorly standardized. A multidisciplinary group of 37 clinicians and scientists participated in a workshop held in May 2005 in Bern, Switzerland to discuss current and future approaches to therapy for 3 eosinophil-mediated disorders: hypereosinophilic syndrome, Churg-Strauss syndrome, and eosinophil-associated gastrointestinal disease. The goal of the workshop was to summarize available data regarding treatment of these disorders to identify the most promising therapies and approaches for further study. There was consensus among all of the participants that the identification of markers of disease progression to assess treatment responses is a research priority for all 3 disorders. Furthermore, the need for newer therapeutic strategies and novel drugs, as well as multicenter trials to assess all treatment modalities, was emphasized.",
keywords = "Churg-Strauss syndrome, Eosinophil, eosinophil-associated gastrointestinal disease, hypereosinophilic syndromes, treatment",
author = "Klion, {Amy D.} and Bochner, {Bruce S.} and Gleich, {Gerald J.} and Nutman, {Thomas B.} and Rothenberg, {Marc E.} and Simon, {Hans Uwe} and Wechsler, {Michael E.} and Weller, {Peter F.} and {the Hypereosinophilic Syndromes Working Group}, {Hypereosinophilic Syndromes Working Group}",
year = "2006",
month = "6",
doi = "10.1016/j.jaci.2006.02.042",
language = "English (US)",
volume = "117",
pages = "1292--1302",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Approaches to the treatment of hypereosinophilic syndromes

T2 - A workshop summary report

AU - Klion, Amy D.

AU - Bochner, Bruce S.

AU - Gleich, Gerald J.

AU - Nutman, Thomas B.

AU - Rothenberg, Marc E.

AU - Simon, Hans Uwe

AU - Wechsler, Michael E.

AU - Weller, Peter F.

AU - the Hypereosinophilic Syndromes Working Group, Hypereosinophilic Syndromes Working Group

PY - 2006/6

Y1 - 2006/6

N2 - Hypereosinophilic syndromes are a heterogeneous group of uncommon disorders characterized by the presence of marked peripheral blood eosinophilia, tissue eosinophilia, or both, resulting in a wide variety of clinical manifestations. Although corticosteroids are the first-line therapy for many of these disorders, approaches to the treatment of patients who do not tolerate or are unresponsive to corticosteroids are poorly standardized. A multidisciplinary group of 37 clinicians and scientists participated in a workshop held in May 2005 in Bern, Switzerland to discuss current and future approaches to therapy for 3 eosinophil-mediated disorders: hypereosinophilic syndrome, Churg-Strauss syndrome, and eosinophil-associated gastrointestinal disease. The goal of the workshop was to summarize available data regarding treatment of these disorders to identify the most promising therapies and approaches for further study. There was consensus among all of the participants that the identification of markers of disease progression to assess treatment responses is a research priority for all 3 disorders. Furthermore, the need for newer therapeutic strategies and novel drugs, as well as multicenter trials to assess all treatment modalities, was emphasized.

AB - Hypereosinophilic syndromes are a heterogeneous group of uncommon disorders characterized by the presence of marked peripheral blood eosinophilia, tissue eosinophilia, or both, resulting in a wide variety of clinical manifestations. Although corticosteroids are the first-line therapy for many of these disorders, approaches to the treatment of patients who do not tolerate or are unresponsive to corticosteroids are poorly standardized. A multidisciplinary group of 37 clinicians and scientists participated in a workshop held in May 2005 in Bern, Switzerland to discuss current and future approaches to therapy for 3 eosinophil-mediated disorders: hypereosinophilic syndrome, Churg-Strauss syndrome, and eosinophil-associated gastrointestinal disease. The goal of the workshop was to summarize available data regarding treatment of these disorders to identify the most promising therapies and approaches for further study. There was consensus among all of the participants that the identification of markers of disease progression to assess treatment responses is a research priority for all 3 disorders. Furthermore, the need for newer therapeutic strategies and novel drugs, as well as multicenter trials to assess all treatment modalities, was emphasized.

KW - Churg-Strauss syndrome

KW - Eosinophil

KW - eosinophil-associated gastrointestinal disease

KW - hypereosinophilic syndromes

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=33646900800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646900800&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2006.02.042

DO - 10.1016/j.jaci.2006.02.042

M3 - Article

C2 - 16750989

AN - SCOPUS:33646900800

VL - 117

SP - 1292

EP - 1302

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 6

ER -